BioSpace News Archive

Moleculin Biotech, Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced that it has entered into definitive agreements with institutional investors to purchase an aggregate of up to 7,500,000 shares

As healthcare costs continue to rise in 2020, Valpak, a leader in local print and digital marketing, recently announced a new way to help their customers save on prescription drugs: ValpakRx.

Belong.Life, creator of the Belong - Beating Cancer Together mobile app, will share a study tomorrow at the ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando showing that cancer patients who had discussions with their doctors about the financial challenges of receiving immunotherapy before beginning treatment were 37.5% more likely to avoid financial toxicity when receiving cancer immunotherapy treatments.

The clinical trials initiated in the United States and in Israel will evaluate safety, tolerability and efficacy of PrimeC, NeuroSense’s product for ALS patients.

The french engineering company FIBROLINE has developed and patented a portfolio of powder impregnation technologies for all types of porous materials.

Atlantic Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted over-the-counter (OTC) clearance to INNOVO®, a non-invasive, clinically proven and wearable device that treats the root cause of bladder weakness, known clinically as stress urinary incontinence (SUI).

Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for Alzheimer’s disease (AD) and related neurodegenerative disorders, announces that the company will be presenting at two conferences this month.

Angela A. Shippy, M.D., FACP, FHM, a tenured member of Memorial Hermann Health System’s senior leadership team, has taken on an expanded role with her recent promotion to Chief Medical Officer.

A well-known market intelligence company, Infiniti Research, has announced the completion of its latest article on identifying key regenerative medicine manufacturing challenges.

Juvare, the leader in critical incident preparedness and response technology, announced today that the company is working closely with public health departments and health systems across the country, in conjunction with the Department of Health and Human Services and the Centers for Disease Control and Prevention, to prepare the U.S. for potential coronavirus outbreaks.